187 related articles for article (PubMed ID: 7485492)
1. Compensatory alterations for insulin signal transduction and glucose transport in insulin-resistant diabetes.
Bonini JA; Colca JR; Dailey C; White M; Hofmann C
Am J Physiol; 1995 Oct; 269(4 Pt 1):E759-65. PubMed ID: 7485492
[TBL] [Abstract][Full Text] [Related]
2. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of insulin signaling components in streptozotocin-treated rats.
Bonini JA; Colca J; Hofmann C
Biochem Biophys Res Commun; 1995 Jul; 212(3):933-8. PubMed ID: 7626133
[TBL] [Abstract][Full Text] [Related]
4. Insulin signaling network -- waiting for Copernicus.
Draznin B
Endocrinology; 1996 Jul; 137(7):2647-8. PubMed ID: 8770881
[No Abstract] [Full Text] [Related]
5. Role of PI 3-kinase and SH-PTP2 in insulin action.
Kasuga M
Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of insulin action--signal transductions after binding to insulin receptor].
Kasuga M
Nihon Naibunpi Gakkai Zasshi; 1993 Nov; 69(10):1029-34. PubMed ID: 8282127
[TBL] [Abstract][Full Text] [Related]
7. Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats.
Begum N; Ragolia L
Metabolism; 1998 Jan; 47(1):54-62. PubMed ID: 9440478
[TBL] [Abstract][Full Text] [Related]
8. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice.
Yamauchi T; Tobe K; Tamemoto H; Ueki K; Kaburagi Y; Yamamoto-Honda R; Takahashi Y; Yoshizawa F; Aizawa S; Akanuma Y; Sonenberg N; Yazaki Y; Kadowaki T
Mol Cell Biol; 1996 Jun; 16(6):3074-84. PubMed ID: 8649419
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
10. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression.
Hofmann CA; Edwards CW; Hillman RM; Colca JR
Endocrinology; 1992 Feb; 130(2):735-40. PubMed ID: 1733721
[TBL] [Abstract][Full Text] [Related]
11. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
Ross SA; Lienhard GE; Lavan BE
Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L
Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
[TBL] [Abstract][Full Text] [Related]
14. Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes.
Gonzalez-Rodriguez A; Clampit JE; Escribano O; Benito M; Rondinone CM; Valverde AM
Endocrinology; 2007 Feb; 148(2):594-608. PubMed ID: 17068137
[TBL] [Abstract][Full Text] [Related]
15. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.
Barbour LA; Shao J; Qiao L; Leitner W; Anderson M; Friedman JE; Draznin B
Endocrinology; 2004 Mar; 145(3):1144-50. PubMed ID: 14633976
[TBL] [Abstract][Full Text] [Related]
16. Insulin signaling in mice expressing reduced levels of Syp.
Arrandale JM; Gore-Willse A; Rocks S; Ren JM; Zhu J; Davis A; Livingston JN; Rabin DU
J Biol Chem; 1996 Aug; 271(35):21353-8. PubMed ID: 8702915
[TBL] [Abstract][Full Text] [Related]
17. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
18. Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome.
Kausch C; Hamann A; Uphues I; Niendorf A; Müller-Wieland D; Joost HG; Algenstaedt P; Dreyer M; Rüdiger HW; Häring HU; Eckel J; Matthaei S
J Clin Endocrinol Metab; 2000 Feb; 85(2):905-18. PubMed ID: 10690909
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats.
Kolter T; Uphues I; Eckel J
Am J Physiol; 1997 Jul; 273(1 Pt 1):E59-67. PubMed ID: 9252480
[TBL] [Abstract][Full Text] [Related]
20. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
